Ralf Mueller, MD

Original Contribution

Evaluation of a New Polymer-Coated Paclitaxel-Eluting Stent
for Treatment of De Novo Lesions: Six-Month Clinical and Angiograph

08/01/2008

Ulrich Gerckens , MD;

Victor Lim , MD;

Ralf Mueller , MD;

Thomas Schmidt , MD;

Lutz Buellesfeld , MD;

Eberhard Grube , MD;

In-stent restenosis as a result of excessive neointimal proliferation is the main limiting factor to the long-term success of coronary stenting, but the advent of drug-eluting stents has reduced this problem significantly. Paclitaxel is an...

In-stent restenosis as a result...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Coronary Stenting with MGuard: First-In-Man Trial

10/08/2008

Eberhard Grube , MD;

Edo Kaluski , MD;

Karl Eugen Hauptmann , MD;

Ralf Mueller , MD;

Steve Tsai , MD;

Marc Klapholz , MD;

ABSTRACT: MGuard is a bare-metal stent covered by an ultra-thin polymer mesh sleeve on its external surface, designed to reduce embolization during coronary, cerebrovascular and peripheral interventions. Aim. To evaluate the feasibility and...

ABSTRACT: MGuard is a bare-metal...

10/08/2008

Journal of Invasive Cardiology